Much remains to be learned about the optimal therapy for patients with juvenile arthritis. Better classification criteria, advances in knowledge of etiopathogenesis, and definition of uniform response criteria are all required. At the present time methotrexate is the only drug that has been shown to be superior to placebo in the treatment of juvenile arthritis. A review of current accepted management strategies is presented.
Therapeutic innovations in the management of juvenile arthritis / R. Cimaz, P. Careddu. - In: PAEDIATRIA CROATICA. - ISSN 1330-1403. - 41:(1997), pp. 87-90.
Therapeutic innovations in the management of juvenile arthritis
R. Cimaz;
1997
Abstract
Much remains to be learned about the optimal therapy for patients with juvenile arthritis. Better classification criteria, advances in knowledge of etiopathogenesis, and definition of uniform response criteria are all required. At the present time methotrexate is the only drug that has been shown to be superior to placebo in the treatment of juvenile arthritis. A review of current accepted management strategies is presented.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
